FamiCord AG (ETR:V3V)

Germany flag Germany · Delayed Price · Currency is EUR
4.720
0.00 (0.00%)
At close: Mar 27, 2026
Market Cap82.28M +15.7%
Revenue (ttm)88.29M +9.5%
Net Income-9.80M
EPS-0.58
Shares Out17.43M
PE Ration/a
Forward PE59.00
Dividendn/a
Ex-Dividend Daten/a
Volume482
Average Volume1,511
Open4.800
Previous Close4.720
Day's Range4.720 - 4.800
52-Week Range3.700 - 7.650
Beta0.70
RSI31.43
Earnings DateApr 30, 2026

About FamiCord AG

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the compa... [Read more]

Sector Healthcare
Founded 1997
Employees 766
Stock Exchange Deutsche Börse Xetra
Ticker Symbol V3V
Full Company Profile

Financial Performance

In 2024, FamiCord AG's revenue was 82.18 million, an increase of 6.65% compared to the previous year's 77.06 million. Losses were -12.14 million, 550.7% more than in 2023.

Financial Statements